Key result
Direct thrombin inhibitors require specific laboratory monitoring strategies, as traditional coagulation tests like PT and PTT have limitations in sensitivity and linearity.
This educational review summarizes the pharmacology, indications, and laboratory monitoring of direct thrombin inhibitors, highlighting the limitations of routine coagulation assays for newer oral agents.
Authors
No takes yet. Share an insight, caveat, or question.
Clinicians must account for PT/PTT limitations when monitoring direct thrombin inhibitors; leaves optimal assay selection open for prospective validation.
George A. Fritsma (2013) conducted a review in Thrombosis / Anticoagulant therapy. Direct Thrombin Inhibitors was evaluated. Direct thrombin inhibitors require specific laboratory monitoring strategies, as traditional coagulation tests like PT and PTT have limitations in sensitivity and linearity.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: